Latest news & articles

Latest news
World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed
Research

World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed

A JDRF-funded, world-first clinical trial has shown that a commonly prescribed rheumatoid arthritis drug (baricitinib) can preserve the body’s own insulin production and suppress the progression of type 1 diabetes (T1D) in those newly diagnosed with the condition. This comes after three decades of research out of the St Vincent’s Institute (SVI) in Melbourne, led […]
New research funding may allow those with type 1 diabetes to make insulin again
Research

New research funding may allow those with type 1 diabetes to make insulin again

JDRF has just funded a new Australian islet transplantation research project with the potential to revert type 1 diabetes. The benefits of islet transplantation Pancreatic islet transplantation is a life-saving and life-changing treatment currently available for people with type 1 diabetes (T1D) who are unaware of their dangerously low blood glucose levels (known as ‘severe […]
Regenerating damaged beta cells in type 1 diabetes ꟷ new funding announced.
Research

Regenerating damaged beta cells in type 1 diabetes ꟷ new funding announced.

JDRF has funded a new Australian research project which may allow those with type 1 diabetes (T1D) to regenerate lost pancreatic cells During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. This leads to the loss and destruction of beta cells, meaning that people with T1D are no longer […]
Research breakthrough shows that antivirals can delay T1D progression
Research

Research breakthrough shows that antivirals can delay T1D progression

A new study suggests that giving antivirals shortly after a type 1 diabetes (T1D) diagnosis may preserve the body’s ability to produce insulin. Recent results from a clinical trial published in the prestigious Nature journal have suggested that administering the antivirals pleconaril and ribavirin can preserve beta cell function in children and teenagers recently diagnosed […]
Type 1 diabetes screening pilot rolls out in primary school for the first time
Research

Type 1 diabetes screening pilot rolls out in primary school for the first time

This World Diabetes Day, on Tuesday 14th November, students from kindergarten and year 4 at Inaburra School in Sydney’s south participated in screening to detect type 1 diabetes (T1D). This is part of the JDRF-funded Australian Type 1 Diabetes National Screening Pilot, a research project looking to identify early-stage T1D in childhood. It was the first […]
Advocacy Spotlight: Freya & Jackie Goldston
Advocacy

Advocacy Spotlight: Freya & Jackie Goldston

Freya has been living with type 1 diabetes (T1D) for 14 years, after being diagnosed at just 11 months old. Since then, Freya and her mum Jackie have been fiercely advocating for the T1D community on behalf of JDRF Australia. We spoke to both Freya and Jackie about their family’s journey with T1D and their […]
Teplizumab shown to slow down type 1 diabetes in those newly diagnosed
Research

Teplizumab shown to slow down type 1 diabetes in those newly diagnosed

Research findings have just been released for the PROTECT clinical trial which tested whether the disease-modifying therapy Teplizumab is able to delay type 1 diabetes (T1D) progression in those newly diagnosed. What is Teplizumab?  Teplizumab is a therapy which has been shown to delay the progression from an early stage of T1D (Stage 2) to […]
Talking with David de George, PhD researcher and Career Support and Travel Grant Recipient
Research

Talking with David de George, PhD researcher and Career Support and Travel Grant Recipient

JDRF Australia’s Career Support and Travel Grants for domestic and international travel are designed to support the next generation of type 1 diabetes (T1D) researchers. They allow early to mid-career researchers and allied health professionals to gain new skills, exchange knowledge, and establish connections and collaborations. We recently spoke to David de George, PhD student […]
JDRF Australia and DrimTel announce new partnership
News

JDRF Australia and DrimTel announce new partnership

JDRF Australia and newly launched telco provider, DrimTel, have announced they are partnering in a move that will support type 1 diabetes (T1D) research breakthroughs while providing the community with technological solutions. DrimTel, which offers Mobile SIM Only, Data Only, and nbn® Plans for residential and business customers, was founded by Ljupco (Lj) Taneski after […]
Innovate in the world of type 1 diabetes: join the Commercialisation Essentials Workshop
Research

Innovate in the world of type 1 diabetes: join the Commercialisation Essentials Workshop

Are you passionate about creating a world where research breakthroughs in type 1 diabetes (T1D) are rapidly turned into tangible treatments; a world where the most promising discoveries don’t just remain in labs but make their way swiftly to those who need them the most? Do you have a pioneering research project, innovative idea, or […]
Advocacy spotlight: Reece & Brittany Wilson
Advocacy

Advocacy spotlight: Reece & Brittany Wilson

At the age of 24, Reece suffered a stroke, and his wife Brittany was diagnosed with an aggressive form of breast cancer. Just nine months into her treatment, Reece was diagnosed with type 1 diabetes (T1D). “For a person living with T1D, the outcome of a cure, recovery or even remission is not an option.” […]
New clinical trial looking for newly diagnosed children and young adults with T1D
Research

New clinical trial looking for newly diagnosed children and young adults with T1D

In people newly diagnosed with type 1 diabetes (T1D) there is often a ‘honeymoon’ phase where some pancreatic beta cells are still able to produce insulin. Committed to improving the lives of those with T1D, JDRF has invested in several clinical studies under the Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC),  investigating whether we can […]
JDRF’s Research Symposium: Bringing researchers together to celebrate past and future type 1 diabetes breakthroughs
Research

JDRF’s Research Symposium: Bringing researchers together to celebrate past and future type 1 diabetes breakthroughs

Bringing researchers together to celebrate past and future type 1 diabetes breakthroughs On the 24th and 25th July 2023, JDRF Australia was delighted to host a research symposium: T1Decade of Research Progress – Past & Future to commemorate over a decade of achievements of the Type 1 Diabetes Clinical Research Network (T1DCRN). The T1DCRN is […]
2023 JDRF Australia PhD scholarships announced
Research

2023 JDRF Australia PhD scholarships announced

JDRF Australia is delighted to announce the recipients of our 2023 PhD top-up scholarships: Rachel Hicks from Western Sydney University and Amanda Purcell from The Kolling Institute. The top-up scholarship is designed to support and encourage PhD students pursuing research in the field of type 1 diabetes (T1D) in line with JDRF’s mission – to […]
JDRF Australia and Cicada Innovations partner to progress research breakthroughs
Research

JDRF Australia and Cicada Innovations partner to progress research breakthroughs

JDRF Australia is excited to announce our partnership with Cicada Innovations, leaders in deep tech incubation to accelerate scientific progress and bridge translation gaps. Our partnership will accelerate type 1 diabetes (T1D) research translation and commercialisation through providing resources, mentorship, funding, and networking opportunities. Our goal is to bring scientific discoveries into real-world solutions for […]
Ethan Greenfield heads to Washington D.C. for the 2023 JDRF International Children’s Congress
Advocacy

Ethan Greenfield heads to Washington D.C. for the 2023 JDRF International Children’s Congress

Ethan Greenfield has been living with type 1 diabetes (T1D) for seven years, after being diagnosed at just four years old. Since then, Ethan, mum Kylie, and the Greenfield family have been fiercely advocating for the T1D community on behalf of JDRF Australia. After years of involvement with JDRF and raising the profile of T1D, […]
Dexcom G6 CGM added to devices available through CGM Subsidy Initiative
Advocacy

Dexcom G6 CGM added to devices available through CGM Subsidy Initiative

The Dexcom G6 Continuous CGM system has been added to the devices available through the Australian Government’s CGM Subsidy Initiative.
Type 1 Diabetes Prevention: Promising Research Breakthrough Gives New Hope
Research

Type 1 Diabetes Prevention: Promising Research Breakthrough Gives New Hope

A research breakthrough, funded by JDRF, has shown a promising future for the prevention of type 1 diabetes. Findings from a study by TrialNet show that the immunotherapy drug teplizumab can delay type 1 diabetes diagnosis a median of 2 years in children and adults at high risk. The study showed that teplizumab interferes with […]